Results 301 to 310 of about 205,978 (334)
Some of the next articles are maybe not open access.
European Journal of Internal Medicine, 2011
Epstein-Barr Virus (EBV) infection has the potential to establish life-long, benign infections in their hosts. Although biochemical evidence of hepatocellular damage is common, jaundice is uncommon and complete recovery is the rule. The present study describes clinical characteristics and changes of liver function tests during the course of infectious ...
Diamantis P, Kofteridis +6 more
openaire +2 more sources
Epstein-Barr Virus (EBV) infection has the potential to establish life-long, benign infections in their hosts. Although biochemical evidence of hepatocellular damage is common, jaundice is uncommon and complete recovery is the rule. The present study describes clinical characteristics and changes of liver function tests during the course of infectious ...
Diamantis P, Kofteridis +6 more
openaire +2 more sources
Epstein–Barr virus as a leading cause of multiple sclerosis: mechanisms and implications
Nature Reviews Neurology, 2023K. Bjørnevik +3 more
semanticscholar +1 more source
The Epstein-Barr virus in autoimmunity
Springer Seminars in Immunopathology, 1995EBV, which is one of the viruses that most of us live with throughout most of our lifetimes, is capable of inducing autoantibodies reactive with a variety of normal tissue proteins. Because of this, the virus remains a constant threat for autoimmunization during our lifetimes, and this threat is in fact realized in several autoimmune diseases.
openaire +2 more sources
Vaccine development for Epstein-Barr Virus
Advances in Experimental Medicine and Biology, 2018Epstein-Barr virus (EBV) is the primary cause of infectious mononucleosis and is associated with several malignancies, including nasopharyngeal carcinoma, gastric carcinoma, Hodgkin lymphoma, Burkitt lymphoma, and lymphomas in immunocompromised persons ...
J. Cohen
semanticscholar +1 more source
Epstein‐Barr virus and gastric carcinoma
Pathology International, 2010Epstein‐Barr virus (EBV) has been accepted as an infective agent causing gastric carcinoma (GC). Epstein‐Barr virus‐associated GC, comprising nearly 10% of all cases of GC, is the monoclonal growth of EBV‐infected epithelial cells, which express several EBV‐latent genes (latency I program).
openaire +3 more sources
Epstein–Barr virus: 40 years on
Nature Reviews. Cancer, 2004L. Young, A. Rickinson
semanticscholar +1 more source
Epstein-barr virus in multiple sclerosis
Current Neurology and Neuroscience Reports, 2009Recent seroepidemiologic and pathologic evidence suggests that prior infection with Epstein-Barr virus (EBV) may be necessary for the development of multiple sclerosis (MS). EBV infects more than 90% of all humans, most of whom remain healthy. In contrast, 99% of MS patients have evidence of prior infection with EBV.
openaire +5 more sources
Epstein–Barr virus-associated lymphomas
Expert Review of Anti-infective Therapy, 2006Following Epstein and colleagues' ground-breaking discovery of Epstein-Barr virus by electron microscopy of Burkitt's lymphoma cell lines, there came the observation that Epstein-Barr virus induces immortalization of B cells in vitro. Thus, initial hopes were of a virus confined to equatorial Africa with a causal link to a particular subtype of ...
openaire +4 more sources
Epstein-Barr Virus EBV and lymphomagenesis
Frontiers in Bioscience, 2002Epstein Barr virus (EBV) is a gamma herpesvirus that is associated with several specific lymphoid malignancies, some of which occur more frequently in immunocompromised individuals. EBV infection is almost ubiquitous in healthy adults, so establishing a causal role in lymphomagenesis has been difficult.
openaire +2 more sources